The endoscopic submucosal dissection market size was valued at USD 324.7 million in 2023, driven by the rising incidence of gastrointestinal cancer cases across the globe. The market is expected to grow at a CAGR of 7.0% during the forecast period of 2024-2032, with the values likely to rise from USD 347.3 million in 2024 to USD 594.5 million by 2032.
Endoscopic submucosal dissection is a minimally invasive procedure conducted to examine and remove precancerous and cancerous areas in the GI (gastrointestinal) tract. It can be used to treat submucosal tumours and lesions. It is done through a tube-like flexible endoscope, which is either through the mouth or the anus. The endoscope is further guided to the irregular growth region to allow tumour marking.
Endoscopic submucosal dissection may be used to treat Barrett’s esophagus (it can cause precancerous lesions), esophagus cancer, colorectal cancer, stomach cancer, and small intestine cancer.
The benefits of endoscopic submucosal dissection outweigh the traditional open surgery by offering a lower risk of complications, faster recovery, and less pain. Therefore, patients and healthcare professionals have shown a strong inclination towards adopting the minimally invasive procedure, resulting in escalated endoscopic submucosal dissection market demand.
To make the prevailing methods more accurate, less time consuming and affordable, technically advanced devices have emerged in the market. Hybrid knives can be considered as one such example. When compared to conventional IT knives, the ClearCut™ hybrid type knife improved the surgical efficacy by facilitating the procedure without any additional device attachment.
The endoscopic submucosal dissection market growth is driven by incessant product launches by established healthcare companies. In April 2023, Olympus launched an entire GI portfolio called EndoClot, which supports hemostasis and endoscopic submucosal dissection or resection lifting. It includes EndoClot adhesive, the EndoClot polysaccharide hemostatic spray and the EndoClot submucosal injection solution.
Penlon Limited also introduced an endoscopic accessories division in the United Kingdom in July 2023. This range of single use accessories offers synchronous bi-directional 360° rotation and accurate positioning, facilitating lower scope of errors in the surgery. With the launch of ClutchCutter and FushKnife, FUJIFILM India, the leading diagnostic and information system service provider announced their expansion in endoscopic solutions portfolio.
Market Breakup by Type
Market Breakup by Indications
Market Breakup by End User
Market Breakup by Region
Colorectal cancer is the third most common category of cancer expected to affect around 153,020 individuals in the United States. Hence, the region is anticipated to lead the endoscopic submucosal dissection market share in the forecast period. With the rising incidence of cancer cases, the government has been working on spreading relevant preventive measures through awareness campaigns. The National Colorectal Cancer Awareness Month set up in February 2023 predominantly focused on early detection through underlying symptoms. The considerable market size can be associated with the presence of key healthcare companies in the area.
While the market has been dominated by North America in the historic period, Asia Pacific is set to experience impressive growth in the future. Along with advanced product launches, government initiatives and foreign investments in the region, there has been significant focus on educating and training the healthcare professionals to use the high-tech medical devices. The Department of Digestive Endoscopy at the Tokyo Women’s Medical University Hospital places prime emphasis on upskilling the staff for safe and efficient endoscopic submucosal dissection procedures. Such measures indicate that the endoscopic submucosal dissection market value will further expand.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type
|Breakup by Indications
|Breakup by End User
|Breakup by Region
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Endoscopic Submucosal Dissection Market Overview
3.1 Global Endoscopic Submucosal Dissection Market Historical Value (2017-2023)
3.2 Global Endoscopic Submucosal Dissection Market Forecast Value (2024-2032)
4 Global Endoscopic Submucosal Dissection Market Landscape
4.1 Global Endoscopic Submucosal Dissection: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Endoscopic Submucosal Dissection: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
5 Global Endoscopic Submucosal Dissection Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Endoscopic Submucosal Dissection Market Segmentation
6.1 Global Endoscopic Submucosal Dissection Market by Type
6.1.1 Market Overview
6.2 Global Endoscopic Submucosal Dissection Market by Indications
6.2.1 Market Overview
6.2.2 Stomach Cancer
6.2.3 Colon Cancer
6.3 Global Endoscopic Submucosal Dissection Market by End User
6.3.1 Market Overview
6.3.3 Ambulatory Surgical Centres
6.3.4 Speciality Clinics
6.4 Global Endoscopic Submucosal Dissection Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Endoscopic Submucosal Dissection Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Endoscopic Submucosal Dissection Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Endoscopic Submucosal Dissection Market
9.1 Market Share by Country
10 Latin America Endoscopic Submucosal Dissection Market
10.1 Market Share by Country
11 Middle East and Africa Endoscopic Submucosal Dissection Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Olympus Corporation
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.2 Boston Scientific Corporation
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.3 FUJIFILM Holdings Corporation
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.4 T Sumitomo Bakelite Co., Ltd.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.5 Creo Medical
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.6 Medtronic plc
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.7 HOYA Corporation
15.7.1 Product Portfolio
15.7.2 Demographic Reach and Achievements
15.7.3 Mergers and Acquisitions
15.8 Ovesco Endoscope AG
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.9 ConMed Corporation
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.10 A Steris PLC
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 324.7 million in 2023, driven by the increasing incidence of gastrointestinal cancer cases, the increasing incidence of gastrointestinal cancer cases.
The market is anticipated to grow at a CAGR of 7.0% during the forecast period of 2024-2032, likely to reach a market value of USD 594.5 million by 2032.
The market demand is driven by the preference of using minimally invasive procedures to offer lower complication risks in patients, coupled with continuous upskilling sessions of the medical professionals to perform the procedure with efficiency and safety.
The continuous arrival of new devices marks as a sign of progress, indicating increased endoscopic submucosal dissection market value in the forecast period. In April 2023, Olympus introduced a portfolio called EndoClot, to support endoscopic submucosal dissection lifting. FUJIFILM India have also launched ClutchCutter and FushKnife, declaring their expansion in endoscopic solutions portfolio.
The major regions of the market include the United States, Japan, EU-4, and the United Kingdom.
It includes grasp, clips, gastroscopes, and colonoscopes.
Stomach cancer and colon cancer are the common indications.
Major end users include hospitals, speciality clinics, and ambulatory surgical centres.
Key players involved in the market are Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, T Sumitomo Bakelite Co., Ltd., Creo Medical, Medtronic plc, HOYA Corporation, Ovesco Endoscope AG, ConMed Corporation, and A Steris PLC.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.